Minnesota Eye Consultants — research payments reported

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$752	1
2023	Research	$8,648	2
2022	Research	$2,338	2
2021	Research	$81,860	20
2020	Research	$21,449	3
2019	Research	$84,762	4

Breakdown

Who paid Research payments · program years 2019–2024

Avedro Inc. $83,360 1 payment
Bausch Health US, LLC $43,320 6 payments
Sight Sciences, Inc. $34,984 5 payments
Kowa Research Institute, Inc. $19,405 12 payments
Aerie Pharmaceuticals, Inc. $16,175 4 payments
Allergan Inc. $1,402 3 payments
Alcon Research LLC $1,164 1 payment

Studies the money was for Research payments · program years 2019–2024

308 $83,360 1 payment
A Phase 3, Multi-Center, Randomized, Double-Masked, Saline-Controlled Trial to Evaluate the Effect of NOV03 (Perfluorohexyloctane) on Signs and Symptoms of Dry Eye Disease Associated with Meibomian Gland Dysfunction (Mojave Study) $43,320 6 payments
A Prospective Multicenter Study of the OMNI Surgical System in Pseudophakic Eyes with Open Angle Glaucoma (ORION) $25,584 2 payments
K-321-201 $19,405 12 payments
A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy (Fuchs) $16,175 4 payments
An Observational Multicenter Clinical Study to Assess the Safety and Effectiveness of the OMNI Surgical System in Pseudophakic Eyes with Primary Open Angle Glaucoma (ORION 2.0) $9,400 3 payments
Efficacy and Safety of Bimatoprost Sustained-Release Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension $1,402 3 payments
A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy (Fuchs) $1,164 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.